Related references
Note: Only part of the references are listed.Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
Philippe Guilpain et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Hendrik Schulze-Koops et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature
Dorra Ben Nessib et al.
THERAPIE (2021)
A guide to vaccinology: from basic principles to new developments
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
Phil-Robin Tepasse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
The known unknowns of T cell immunity to COVID-19
Annika C. Karlsson et al.
SCIENCE IMMUNOLOGY (2020)
Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
Jin Kyun Park et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy
Kevin L. Winthrop et al.
ARTHRITIS RESEARCH & THERAPY (2019)
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
Kevin L. Winthrop et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
Kevin L. Winthrop et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
Rieke Alten et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases - a longitudinal study
Lara Fischer et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
Alan J. Kivitz et al.
JOURNAL OF RHEUMATOLOGY (2014)
Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab
Tomomi Tsuru et al.
MODERN RHEUMATOLOGY (2014)
Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Charlotte Hua et al.
ARTHRITIS CARE & RESEARCH (2014)
Abatacept and Reduced Immune Response to Pandemic 2009 Influenza A/H1N1 Vaccination in Patients With Rheumatoid Arthritis
Ana C. Ribeiro et al.
ARTHRITIS CARE & RESEARCH (2013)
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
Meliha Crnkic Kapetanovic et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
Shunsuke Mori et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Protective effect of A/H1N1 vaccination in immune-mediated disease-a prospectively controlled vaccination study
Sabine Adler et al.
RHEUMATOLOGY (2012)
TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients
Ivan Leonardo Avelino Franca et al.
RHEUMATOLOGY (2012)
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S. van Assen et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate
Elizabeth Coulson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Impact of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs on Antibody Responses to the AS03-Adjuvanted Pandemic Influenza Vaccine A Prospective, Open-Label, Parallel-Cohort, Single-Center Study
Cem Gabay et al.
ARTHRITIS AND RHEUMATISM (2011)
The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
U. Arad et al.
VACCINE (2011)
Humoral Responses After Influenza Vaccination Are Severely Reduced in Patients With Rheumatoid Arthritis Treated With Rituximab
Sander van Assen et al.
ARTHRITIS AND RHEUMATISM (2010)
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Ori Elkayam et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial
Maryam Keshtkar-Jahromi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response
S. Oren et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Vaccination against influenza in rheumatoid arthritis:: the effect of disease modifying drugs, including TNFα blockers
I Fomin et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
MC Kapetanovic et al.
RHEUMATOLOGY (2006)
Share Paper
